Health X Platform Limited (HEALTHX) Earnings Call Transcripts

Health X Platform Limited's Latest Earnings Call - June 12, 2026

In Q4 FY '26, Health X Platform Limited reported a revenue of INR 356 crores, reflecting a 22% year-on-year growth, and a full-year revenue of INR 1,283 crores, up 18% YoY. The company continues to improve operational metrics, with reduced EBITDA losses of INR 20 crores for the quarter and INR 65 crores for the fiscal year. Management maintained its long-term revenue target of INR 6,000 crores by FY '30, signaling confidence in growth drivers such as the Jito initiative and expansion of the B2B and B2C platforms.

Reported metrics

Guidance from management

Management maintained its long-term revenue target of INR 6,000 crores by FY '30 and expects to improve EBITDA margins to around 5% at that revenue level.

What management said

Jito, we have launched in both B2B and B2C platform. So there is no negative surprises there is positive surprises and sales are going -- this is the first quarter only. So before the meaningful figures come in, we can discuss for the next quarter. So this quarter is the losing year. So in a few lakhs sales around, say, INR 30 lakhs per month we are doing. So it will take time to build up. But yes, the start is very ...

This is too early to discuss anything. There is no meaningful conclusion can be drawn into this is the second month only. So I mean -- but yes, if you want to divide it, then you can divide it 2/3 is coming from retail, 1/3 from Sasu.

What analysts pressed on

Analysts expressed concerns regarding the pace of growth in the B2C segment and the impact of the demerger on operational focus. They also inquired about the readiness of the market for AI-driven solutions and the timeline for profitability in the Healthbuddy segment.

Main topics on the call

• Revenue Growth — Health X reported a revenue of INR 356 crores for Q4 FY '26, a 22% increase YoY. The full-year revenue reached INR 1,283 crores, an 18% growth, driven by both B2B and B2C segments.
• Improvement in Operational Metrics — The company reduced its EBITDA losses to INR 20 crores in Q4 from INR 29 crores YoY, indicating improved operational efficiency. EBITDA margin improved to negative 5.5% from negative 10.3% in the prior year.
• Launch of Jito — The Jito initiative aims to offer generic medicines at prices up to 60% lower than branded alternatives. Management indicated positive early sales, with INR 30 lakhs per month, although they expect significant growth in ...
• Strategic Focus on Technology — Health X emphasized its commitment to technology and automation, with a centralized fulfillment infrastructure and AI-driven processes. This is expected to enhance efficiency and support future growth.

Read the full Health X Platform Limited transcript (June 12, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 5 Health X Platform Limited earnings call transcripts on record, spanning February 2, 2024 to August 11, 2026. Based on this history, Health X Platform Limited reports annually. The most recent call on file is dated August 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

HEALTHX

Exchange

NSEI

Country

IN

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

5

First call

February 2, 2024

Most recent

August 11, 2026

Reporting cadence

annually